MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/prca.200780017

Медицинская библиотека · Proteomics. Clinical applications · 2008

Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis.

Kumari Shraddha, Kumar Awanish, Samant Mukesh, Sundar Shyam, Singh Neeloo, Dube Anuradha

СтатьяПеревод пока не подготовлен

Аннотация

Visceral leishmaniasis (VL) is the most devastating type caused by Leishmania donovani, Leishmania infantum, and Leishmania chagasi. The therapeutic mainstay is still based on the antiquated pentavalent antimonial against which resistance is now increasing. Unfortunately, due to the digenetic life cycle of parasite, there is significant antigenic diversity. There is an urgent need to develop novel drug/vaccine targets against VL for which the primary goal should be to identify and characterize the structural and functional proteins. Proteomics, being widely employed in the study of Leishmania seems to be a suitable strategy as the availability of annotated sequenced genome of Leishmania major has opened the door for dissection of both protein expression/regulation and function. Advances in clinical proteomic technologies have enable to enhance our mechanistic understanding of virulence/pathogenicity/host-pathogen interactions, drug resistance thereby defining novel therapeutic/vaccine targets. Expression proteomics exploits the differential expression of leishmanial proteins as biomarkers for application towards early diagnosis. Further using immunoproteomics efforts were also focused on evaluating responses to define parasite T-cell epitopes as vaccine/diagnostic targets. This review has highlighted some of the relevant developments in the rapidly emerging field of leishmanial proteomics and focus on its future applications in drug and vaccine discovery against VL.

Для цитирования: Kumari Shraddha, Kumar Awanish, Samant Mukesh, Sundar Shyam, Singh Neeloo, Dube Anuradha. Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis.. Proteomics. Clinical applications. 2008. DOI: 10.1002/prca.200780017.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.